Kim, W. R. et al. MELD 3.0: the model for end-stage liver disease updated for the modern era. Gastroenterology 161, 1887–1895.e4 (2021).
Kim, W. R., Mannalithara, A., Kwo, P. Y., Bonham, C. A. & Kwong, A. Mortality in patients with end‐stage liver disease above model for end‐stage liver disease 3.0 of 40. Hepatology 77, 851–861 (2023).
Markmann, J. F. et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS liver PROTECT randomized clinical trial. JAMA Surg. 157, 189–198 (2022).
Article PubMed PubMed Central Google Scholar
Ravaioli, M. et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-A randomized clinical trial. Am. J. Transpl. 22, 2401–2408 (2022).
Schlegel, A. et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. J. Hepatol. 78, 783–793 (2023).
Article CAS PubMed Google Scholar
Chapman, W. C. et al. Normothermic machine perfusion of donor livers for transplantation in the United States: a randomized controlled trial. Ann. Surg. 278, e912–e921 (2023).
Guo, Z. et al. A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease. J. Hepatol. 79, 394–402 (2023).
Suh, K.-S. et al. Pure laparoscopic living donor liver transplantation: dreams come true. Am. J. Transpl. 22, 260–265 (2022).
Hong, S. K. et al. Long-term survival of 10,116 Korean live liver donors. Ann. Surg. 274, 375–382 (2021).
Toshima, T. et al. Aborted living-donor liver transplantation in the real-world setting, lessons from 13,937 cases of Vanguard Multi-center Study of International Living Donor Liver Transplantation Group. Am. J. Transplant. https://doi.org/10.1016/j.ajt.2023.07.011 (2023).
Comments (0)